Repertoire Immune Medicines
Ewen Cameron has a diverse work experience in the fields of biotechnology and medical research. Ewen is currently working as a Sr Principal and Co-Founder at Flagship Pioneering and Repertoire Immune Medicines respectively since 2016. Prior to this, they gained significant expertise as a Postdoctoral Fellow at the Massachusetts Institute of Technology (MIT) from 2010 to 2016. Ewen started their career as a Research Technician at the London School of Hygiene & Tropical Medicine from 2002 to 2003.
Ewen Cameron holds a PhD in Microbiology and Molecular Genetics from Harvard University. Prior to their doctoral studies, they earned a BS degree in Molecular Biology from Yale University. No specific start and end years for both degrees were provided.
This person is not in any teams
Repertoire Immune Medicines
2 followers
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.